Algernon Pharmaceuticals Alzheimer Diagnostic and Treatment Clinic Interview

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare and clinical stage drug development company, is pleased to announce it has closed the acquisition to acquire 100% of the issued and outstanding shares of NoBrainer Imaging Centers, Inc.

Format

Vimeo

Source

Algernon Pharmaceuticals Inc.